STAAR SURGICAL COMPA

STAA
Delayed Quote. Delayed  - 04/09 04:00:00 pm
115.95USD +0.84%
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: January 2020 2021
Net sales1 163203
EBITDA1 -13,2
Operating profit (EBIT)1 6,7711,1
Operating Margin 4,14%5,44%
Pre-Tax Profit (EBT)1 8,2711,6
Net income1 5,918,44
Net margin 3,62%4,15%
EPS2 0,120,19
Dividend per Share --
Last update 02/24/2021-
1 USD in Million
2 USD
Estimates
Finances - Leverage
Fiscal Period: January 2020 2021
Net Debt --
Net Cash position --
Leverage (Debt / EBITDA) --
Free Cash Flow1 12,5-7,38
ROE (Net Profit / Equities) 3,31%4,80%
Shareholders' equity1 179176
ROA (Net Profit / Asset) 2,54%3,70%
Assets1 232228
Book Value Per Share --
Cash Flow per Share --
Capex1 8,4011,5
Capex / Sales 5,14%5,65%
Last update 02/24/202104/08/2021
1 USD in Million
Estimates
Balance Sheet Analysis
Financial Ratios
Size 2021e 2022e
Capitalization 5 398 M $ -
Valuation 2021e 2022e
P/E ratio (Price / EPS) 602x 156x
Capitalization / Revenue 26,5x 20,0x
Yield (DPS / Price) - -
Price to book (Price / BVPS) - -
Profitability 2021e 2022e
Operating Margin (EBIT / Sales) 5,44% 17,2%
Operating Leverage (Delta EBIT / Delta Sales) 2,59x 9,77x
Net Margin (Net Profit / Revenue) 4,15% 13,5%
ROA (Net Profit / Asset) 3,70% 18,0%
ROE (Net Profit / Equities) 4,80% 22,0%
Rate of Dividend - -
Balance Sheet Analysis 2021e 2022e
CAPEX / Sales   5,65% 3,71%
Cash Flow / Sales - -
Capital Intensity (Assets / Sales) 1,12x 0,75x
Financial Leverage (Net Debt / EBITDA) - -
Price Earning Ratio
EPS & Dividend